anti-CD7 CAR-T cell therapy (Institute of Hematology & Blood Disease Hospital)

N/A

Report date: 2025/03/14 16:48:19

Base Information

Drug Nameanti-CD7 CAR-T cell therapy (Institute of Hematology & Blood Disease Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionT-cell antigen CD7 modulators

TargetsT-cell antigen CD7

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHematology Hospital Of Chinese Academy Of Medical Sciences

China Registration ClassN/A

Develop Information

Active CompaniesHematology Hospital Of Chinese Academy Of Medical Sciences

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A